» Articles » PMID: 16857950

Macrophage ABCG1 Deletion Disrupts Lipid Homeostasis in Alveolar Macrophages and Moderately Influences Atherosclerotic Lesion Development in LDL Receptor-deficient Mice

Overview
Date 2006 Jul 22
PMID 16857950
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: ABCG1 has recently been identified as a facilitator of cellular cholesterol and phospholipid efflux to high-density lipoprotein (HDL). Its expression in macrophages is induced during cholesterol uptake in macrophages and by liver X receptor (LXR). The role of macrophage ABCG1 in atherosclerotic lesion development is, however, still unknown.

Methods And Results: To assess the role of macrophage ABCG1 in atherosclerosis, we generated low-density lipoprotein (LDL) receptor knockout (LDLr-/-) mice that are selectively deficient in macrophage ABCG1 by using bone marrow transfer (ABCG1-/- --> LDLr-/-). Peritoneal macrophages isolated from donor ABCG1-/- mice exhibited a 22% (P=0.0007) decrease in cholesterol efflux to HDL. To induce atherosclerosis, transplanted mice were fed a high-cholesterol diet containing 0.25% cholesterol and 15% fat for 6 and 12 weeks. Serum lipid levels and lipoprotein profiles did not differ significantly between ABCG1-/- --> LDLr-/- mice and controls. In lungs of ABCG1-/- --> LDLr-/- mice a striking accumulation of lipids was observed in macrophages localized to the subpleural region. After 6 weeks of high-cholesterol diet feeding the atherosclerotic lesion size was 49+/-12x10(3) microm2 for ABCG1+/+ --> LDLr-/- mice versus 65+/-15x103 microm2 for ABCG1-/- --> LDLr-/- mice and after 12 weeks of high-cholesterol diet feeding 124+/-17x10(3) microm2 for ABCG1+/+ --> LDLr-/- mice versus 168+/-17x10(3) microm2 for ABCG1-/- --> LDLr-/- mice. Atherosclerotic lesion size depended on both time and the macrophage ABCG1 genotype (P=0.038 by 2-way ANOVA, n > or = 8), indicating a moderately 33% to 36% increase in lesion formation in the absence of macrophage ABCG1.

Conclusions: Macrophage ABCG1 deficiency does lead to heavy lipid accumulation in macrophages of the lung, and also a moderately significant effect on atherosclerotic lesion development was observed.

Citing Articles

Biological Functions and Clinical Significance of the ABCG1 Transporter.

Kotlyarov S, Kotlyarova A Biology (Basel). 2025; 14(1).

PMID: 39857239 PMC: 11760449. DOI: 10.3390/biology14010008.


Evaluation of Minimum-to-Severe Global and Macrovesicular Steatosis in Human Liver Specimens: A Portable Ambient Light-Compatible Spectroscopic Probe.

Guo H, Stueck A, Doppenberg J, Chae Y, Tikhomirov A, Zeng H J Biophotonics. 2024; 17(12):e202400292.

PMID: 39396823 PMC: 11614560. DOI: 10.1002/jbio.202400292.


IGFBPL1 inhibits macrophage lipid accumulation by enhancing the activation of IGR1R/LXRα/ABCG1 pathway.

Hou L, Feng X, Zhu Z, Mi Y, He Q, Yin K Aging (Albany NY). 2023; 15(24):14791-14802.

PMID: 38157252 PMC: 10781499. DOI: 10.18632/aging.205301.


Metabolic and functional remodeling of colonic macrophages in response to high-fat diet-induced obesity.

Castoldi A, Sanin D, van Teijlingen Bakker N, Aguiar C, de Brito Monteiro L, Rana N iScience. 2023; 26(10):107719.

PMID: 37674984 PMC: 10477064. DOI: 10.1016/j.isci.2023.107719.


HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy.

Linton M, Yancey P, Tao H, Davies S Circ Res. 2023; 132(11):1521-1545.

PMID: 37228232 PMC: 10213997. DOI: 10.1161/CIRCRESAHA.123.321563.